Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Mkilloran who wrote (21234)	4/23/1999 8:13:00 AM
From: Sidney Merle Foster	Respond to of 23519

I don't think ALIBRA will ever be OTC because of the method of delivery. A cream, if ever produced, may be closer to OTC. Hope I'm wrong. Sid

To: Mkilloran who wrote (21234)	4/23/1999 8:16:00 AM
From: Tim Davies	Respond to of 23519

what is alebra?. I think one of the main problems in the domestice sales of muse is the fact that it costs 3 times more than viagra, and isnt promoted very much. They really need to spend some of that income from agency agrements on domestic marketing. I wonder if there cost structure is so high that there isnt the room for a good profit to a large marketing firm. imo the viagra deaths have to be put in perspective.. the folks are 55 plus and have medical issues that really mean that they shouldnt be taking the stuff. That aside i really feel that with competative pricing and strong marketing the muse product would be seen as a viable competetor. tim

To: Mkilloran who wrote (21234)	4/23/1999 8:18:00 AM
From: blankmind	Read Replies (1) \| Respond to of 23519

- if they sold Albibra over the counter - Vivus goes to $100+ overnight - no joke - in Thailand & some other countries, I believe something like Alibra would be sold over the counter - unfortunately, in America, unless the Clinton tainted FDA gives the okay, we have to go thru a gov't licensed gatekeeper to get it.